UCSF, Stanford and Johns Hopkins join FDA partners…


At a time when Big Pharma is increasingly tapping academic institutions for expertise in informatics and data-driven computer models for drug discovery, the FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco (UCSF) for a new initiative aimed at streamlining the drug development and approval process. Under the FDA’s Centers of Excellence in Regulatory Science…
Read More
Gates, Wellcome bet $40M on Kymab’s antibody…
Cambridge, U.K.’s Kymab touts its drug development platform as an ideal way to spotlight new antibodies, Check out the post right here to understand how antibodies help to neutralize the toxins in the body. Toxins are the damaging and poisonous substances that are produced by various different organisms. Antibodies help to activate some protein groups that are a part of the immune system of the body. These are called the complement and this is what is responsible to kill the virus and bacteria and some bright minds would seem to agree, as the Wellcome Trust and Bill and Melinda Gates Foundation have teamed up on a $40 million round for the biotech. Under the Series B terms, each organization will hand over $20 million to support the company’s Kymouse technology, a genetically engineered mouse…
Read More
Seattle BioMed receives $10M NIAID grant to lead A…
The National Institute of Allergy and Infectious Diseases has awarded a 7-year, $9.8 million grant to develop an AIDS vaccine to four Seattle-based research organizations and Rockefeller University. The nonprofit Seattle Biomedical Research Institute will lead the research team, which will be made up of researchers from the University of Washington, Fred Hutchinson Cancer Research Center, Seattle Children’s Hospital and…
Read More
UK “breakthrough” drug program
Impressed by the success of the FDA’s breakthrough therapy designation, U.K. regulators are considering a similar effort to speed the path for promising drugs, according to an industry group. The nation’s government is in the midst of “active discussion across Whitehall” on a plan that would fast-track certain treatments, according to the trade group U.K. BioIndustry Association. Under the proposal,…
Read More
AstraZeneca, Bristol-Myers grant for diabetes rese…
AstraZeneca’s ($AZN) and Bristol-Myers Squibb’s ($BMY) U.S. Diabetes Alliance is giving a three-year, $5 million grant to the American Diabetes Association’s Pathway to Stop Diabetes program. The Pathway initiative provides up to $1.6 million in support for 5 to 7 years to selected investigators to help fund research relevant to any diabetes type, diabetes-related disease state or diabetes…
Read More
The NCI is offering $20M to projects that move can…
The National Cancer Institute (NCI) faces a growing data problem. As the scale of its projects grows–one initiative is expected to generate 2.5 petabytes of data–downloading results for analysis on local systems becomes impractical. Recognizing this, the NCI has allocated $20 million for cloud-based genomics pilot projects. Having spent last year gathering feedback on what users want from cloud-based cancer…

Share:

You might also like …